Shares of Celsius Holdings Inc. (CELH) have gained 4.8% over the past four weeks to close the last trading session at $35.52, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $44.63 indicates a potential upside of 25.7%. The average comprises 16 short-term price targets ranging from a low of $30 to a high of $58, with a standard deviation of $7.44. While the lowest estimate indic ...

Vishay Intertechnology (VSH) came out with a quarterly loss of $0.03 per share in line with the Zacks Consensus Estimate. This compares to earnings of $0.22 per share a year ago. These figures are adjusted for non-recurring items. A quarter ago, it was expected that this chipmaker would post earnings of $0.11 per share when it actually produced break-even earnings, delivering a surprise of -100%. There are no easy answers to this key question, but one reliable measure that can help investors address this is ...

Shares of Integer (ITGR) have gained 3.2% over the past four weeks to close the last trading session at $116.55, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $150.38 indicates a potential upside of 29%.The mean estimate comprises eight short-term price targets with a standard deviation of $6.95. While the lowest estimate of $140 indicates a 20.1% increase from the current pri ...

Group 1 - Orion Marine Group (ORN) shares have increased by 40.4% in the past four weeks, closing at $7.16, with a mean price target of $11 indicating a potential upside of 53.6% [1] - The mean estimate consists of four short-term price targets with a standard deviation of $2.16, where the lowest estimate of $9 suggests a 25.7% increase, and the highest estimate of $14 indicates a 95.5% surge [2] - Analysts show strong agreement in revising earnings estimates higher, with a 128.6% increase in the Zacks Consensus Estimate for the current year, indicating positive earnings prospects for ORN [11][12] Group 2 - ORN holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates, suggesting a strong potential upside in the near term [13] - The clustering of price targets with a low standard deviation reflects a high degree of agreement among analysts regarding the stock's price movement direction [9] - While price targets are often viewed skeptically, the direction implied by them can serve as a useful guide for further research into the stock's potential [10]

Shares of Kodiak Gas Services (KGS) have gained 8.8% over the past four weeks to close the last trading session at $34.16, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $43.73 indicates a potential upside of 28%.The average comprises 11 short-term price targets ranging from a low of $35 to a high of $51, with a standard deviation of $4.78. While the lowest estimate indicates a ...

Core Viewpoint - OneSpan (OSPN) shares have increased by 11.8% in the past four weeks, closing at $15.17, with a potential upside indicated by Wall Street analysts' price targets suggesting a mean estimate of $19.33, representing a 27.4% upside [1] Price Targets and Estimates - The average price targets range from a low of $15 to a high of $23, with a standard deviation of $4.04, indicating variability among analysts [2] - The lowest estimate suggests a decline of 1.1%, while the highest estimate indicates a potential upside of 51.6% [2] - Analysts' consensus on price targets should be approached with caution, as their ability to set unbiased targets has been questioned [3][7] Earnings Estimates and Analyst Agreement - Analysts are optimistic about OSPN's earnings prospects, with a strong agreement in revising EPS estimates higher, which correlates with potential stock price movements [4][11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 5.4%, with one estimate moving higher and no negative revisions [12] Zacks Rank and Investment Implications - OSPN holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates [13] - While consensus price targets may not reliably indicate the extent of potential gains, they can provide guidance on the direction of price movement [13]

Group 1 - Constellium (CSTM) shares have increased by 38.2% in the past four weeks, closing at $11.04, with a mean price target of $16.60 indicating a potential upside of 50.4% [1] - The average price targets range from a low of $12 to a high of $24, with a standard deviation of $4.77, suggesting variability in analyst estimates [2] - Analysts show strong agreement on CSTM's ability to report better earnings, with a positive trend in earnings estimate revisions correlating with potential stock price increases [4][11] Group 2 - Over the last 30 days, the Zacks Consensus Estimate for CSTM's current year earnings has increased by 14.6%, with two estimates moving higher and no negative revisions [12] - CSTM holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - While consensus price targets may not be reliable for predicting exact gains, they can indicate potential price movement direction [13]

Shares of Align Technology (ALGN) have gained 15.8% over the past four weeks to close the last trading session at $177.61, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $233.42 indicates a potential upside of 31.4%.The average comprises 12 short-term price targets ranging from a low of $170 to a high of $275, with a standard deviation of $31.09. While the lowest estimate indic ...

Core Viewpoint - American Well Corporation (AMWL) has seen an 11.8% increase in share price over the past four weeks, closing at $7.31, with a potential upside of 46.5% based on Wall Street analysts' mean price target of $10.71 [1][11]. Price Targets and Analyst Estimates - The mean price target is derived from seven short-term estimates with a standard deviation of $2.58, indicating variability among analysts [2]. - The lowest estimate is $7.50, suggesting a 2.6% increase, while the highest estimate predicts a surge of 105.2% to $15 [2]. - A low standard deviation signifies strong agreement among analysts regarding the stock's price direction [9]. Earnings Estimates and Market Sentiment - Analysts have shown increasing optimism about AMWL's earnings prospects, as evidenced by a positive trend in earnings estimate revisions [11]. - Over the past 30 days, one estimate has increased, leading to a 6.7% rise in the Zacks Consensus Estimate for the current year [12]. - AMWL holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for upside [13].

Summit Therapeutics PLC (SMMT) closed the last trading session at $28.02, gaining 61.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $37.38 indicates a 33.4% upside potential.The mean estimate comprises eight short-term price targets with a standard deviation of $5.71. While the lowest estimate of $30 indicates a 7.1% increase from the current price level, the most optimistic an ...